We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+6.65%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$19.3B
AUM Growth
+$276M
(+1.5%)
Cap. Flow
-$864M
Cap. Flow
% of AUM
-4.48%
Top 10 Holdings %
Top 10 Hldgs %
44.33%
Holding
252
New
9
Increased
38
Reduced
113
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$6.63M |
| 2 |
Enterprise Products Partners
EPD
|
+$4.91M |
| 3 |
Southwest Airlines
LUV
|
+$2.98M |
| 4 |
Wynn Resorts
WYNN
|
+$925K |
| 5 |
Blackstone
BX
|
+$894K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$89.2M |
| 2 |
Altria Group
MO
|
+$51.7M |
| 3 |
Philip Morris
PM
|
+$46.8M |
| 4 |
Apple
AAPL
|
+$46.8M |
| 5 |
ExxonMobil
XOM
|
+$30.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 29.2% |
| 2 | Financials | 18.48% |
| 3 | Energy | 15.07% |
| 4 | Technology | 10.96% |
| 5 | Healthcare | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
American Electric Power
AEP
$70.4B
| $244K | ﹤0.01% |
3,318
| – | – |
|
227
Cullen/Frost Bankers
CFR
$10.5B
| $243K | ﹤0.01% |
2,569
-100
| -4% | -$9.63K |
|
228
Adobe
ADBE
$105B
| $241K | ﹤0.01% |
+1,377
| New | +$237K |
|
229
Idexx Laboratories
IDXX
$44.9B
| $238K | ﹤0.01% |
1,520
| – | – |
|
230
Omnicom Group
OMC
$23.5B
| $237K | ﹤0.01% |
3,249
| – | – |
|
231
Dominion Energy
D
$62B
| $232K | ﹤0.01% |
2,866
+125
| +5% | +$10.1K |
|
232
General Motors
GM
$80.9B
| $230K | ﹤0.01% |
5,600
+599
| +12% | +$26K |
|
233
Howard Hughes
HHH
$3.94B
| $229K | ﹤0.01% |
1,827
| – | – |
|
234
International Paper
IP
$22.6B
| $226K | ﹤0.01% |
+4,124
| New | +$221K |
|
235
Yum China
YUMC
$15.7B
| $222K | ﹤0.01% |
5,540
| – | – |
|
|
DNKN
236
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $221K | ﹤0.01% |
+3,430
| New | +$200K |
|
|
MXIM
237
DELISTED
Maxim Integrated Products
MXIM
| $219K | ﹤0.01% |
+4,194
| New | +$218K |
|
|
COL
238
DELISTED
Rockwell Collins
COL
| $219K | ﹤0.01% |
1,613
| – | – |
|
239
Ford
F
$60.9B
| $216K | ﹤0.01% |
17,313
+4,614
| +36% | +$56.8K |
|
240
MPLX
MPLX
$58.6B
| $213K | ﹤0.01% |
5,995
| – | – |
|
241
Acuity Brands
AYI
$9.99B
| $210K | ﹤0.01% |
1,194
| – | – |
|
|
FBSS
242
DELISTED
Fauquier Bankshares Inc
FBSS
| $210K | ﹤0.01% |
+9,600
| New | +$199K |
|
|
SRCL
243
DELISTED
Stericycle Inc
SRCL
| $204K | ﹤0.01% |
3,000
| – | – |
|
244
eBay
EBAY
$51.2B
| $203K | ﹤0.01% |
5,378
-1,010
| -16% | -$37.5K |
|
|
PLXP
245
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $95K | ﹤0.01% |
13,729
| – | – |
|
|
ROX
246
DELISTED
Castle Brands, Inc.
ROX
| $64K | ﹤0.01% |
52,830
| – | – |
|
247
W&T Offshore
WTI
$525M
| $39K | ﹤0.01% |
11,858
| – | – |
|
248
NanoViricides
NNVC
$39.3M
| $25K | ﹤0.01% |
1,429
| – | – |
|
249
Bruker
BRKR
$9.4B
| – | – |
-7,060
| Closed | -$210K |
|
250
Carlisle Companies
CSL
$13.5B
| – | – |
-2,135
| Closed | -$214K |
|
Similar funds
HF
Fayez Sarofim & Co's Q4 2017 Portfolio in Review
As of Q4 2017, Fayez Sarofim & Co held 252 positions worth $19.3B, up 1.5% from $19B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Fayez Sarofim & Co withdrew a net $864M in Q4 2017, closing 4 positions and reducing 113 holdings. Its most notable exit was Celgene Corp, an estimated $89.2M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 29% of assets, down from 30% a quarter earlier, followed by Financials and Energy.
Against the trend, Fayez Sarofim & Co opened a new position in Blackstone worth $879K.
- Fayez Sarofim & Co's largest Q4 2017 buy was Blackstone: 27,466 shares worth $879K.
- Fayez Sarofim & Co added most to Royal Dutch Shell PLC ADS Class A in Q4 2017, an estimated $6.63M increase.
- Fayez Sarofim & Co's biggest Q4 2017 reduction was Altria Group, cutting an estimated $51.7M.
- Fayez Sarofim & Co fully exited Celgene Corp in Q4 2017, selling an estimated $89.2M.
- Fayez Sarofim & Co's ten largest holdings make up 44% of its $19.3B portfolio in Q4 2017.
- Fayez Sarofim & Co opened 9 new positions and closed 4 in Q4 2017.
- Fayez Sarofim & Co's portfolio value rose 1.5% quarter-over-quarter to $19.3B.
Based on Fayez Sarofim & Co's 13F filing for Q4 2017, filed 13 Feb 2018.